Causes of Gynecomastia with Normal Laboratory Results
When laboratory tests are normal in a patient with gynecomastia, the most common causes are idiopathic gynecomastia (accounting for approximately 50-58% of cases), medication-induced gynecomastia, and pseudogynecomastia (fatty tissue deposition rather than true glandular enlargement). 1, 2
Primary Etiologies When Labs Are Normal
Idiopathic Gynecomastia
- Most frequent diagnosis when all laboratory and imaging studies return normal 1, 2
- Strongly associated with increased body weight, elevated BMI, and higher body fat percentage 2
- Can present as either persistent pubertal gynecomastia or late-onset adult form
- Linked to increased peripheral conversion of testosterone to estradiol in adipose tissue, even when circulating hormone levels appear normal 2
Medication-Induced Gynecomastia
This is a critical and often overlooked cause that occurs despite normal hormonal labs 1. Key offending agents include:
- H2-receptor antagonists (cimetidine, ranitidine) 2, 3
- Proton pump inhibitors - implicated in over 25% of gynecomastia cases in recent studies 3
- Psychoactive medications (antipsychotics, antidepressants) 2, 4
- Spironolactone and other cardiovascular drugs 5
- Recreational drugs (marijuana, anabolic steroids, alcohol) 1
Pseudogynecomastia
- Excess fatty tissue deposition without true glandular proliferation 1
- Particularly common in patients with elevated body mass index
- Can be definitively distinguished from true gynecomastia by imaging (mammography or ultrasound) 1
- Important to identify as it requires different management (weight loss vs. medical/surgical treatment)
Clinical Approach Algorithm
Step 1: Detailed Medication History
- Review ALL current and recent medications, including over-the-counter drugs, supplements, and herbal products
- Specifically ask about H2 blockers, PPIs, psychotropic medications, and recreational drug use
- Consider temporal relationship between medication initiation and gynecomastia onset
Step 2: Anthropometric Assessment
- Measure body weight, BMI, and assess body fat distribution
- Higher BMI and increased adiposity strongly correlate with idiopathic gynecomastia even when hormones are normal 2
Step 3: Physical Examination Characteristics
- True gynecomastia: soft, rubbery, or firm mobile mass directly under the nipple 1
- Pseudogynecomastia: diffuse fatty tissue without discrete subareolar mass
- Bilateral involvement in approximately 50% of cases 1
- Pain more common in gynecomastia present <6 months 1
Step 4: Consider Occult Liver Disease
- Chronic liver disease can cause gynecomastia even with initially normal standard labs 1
- May require more specific hepatic function testing if clinical suspicion exists
Important Clinical Pitfalls
Do not assume normal labs exclude all pathology: The most recent evidence suggests that up to 50% of gynecomastia cases remain idiopathic even after complete evaluation, and circulating hormone levels may not reflect local tissue hormone metabolism 4. A 2026 study found that E2/T ratios did not significantly differ between patients and controls, emphasizing that local tissue factors and medication effects are often more important than systemic hormone levels 4.
Medication review is mandatory: Drug-induced gynecomastia is frequently missed because providers don't systematically review all medications. PPIs alone account for >25% of cases in recent series 3.
Obesity is not just a risk factor—it's mechanistic: Increased adipose tissue enhances peripheral aromatization of androgens to estrogens at the tissue level, which may not be reflected in serum measurements 2. Weight reduction should be the first-line intervention in overweight patients with idiopathic gynecomastia.
Pseudogynecomastia requires different management: If imaging confirms only fatty tissue without glandular proliferation, medical therapy targeting hormonal pathways will be ineffective 1.
When to Image Despite Normal Labs
Imaging is not routinely indicated when physical examination is consistent with benign gynecomastia or pseudogynecomastia 1. However, consider imaging if:
- Physical examination findings are indeterminate
- Clinical presentation raises concern for malignancy (hard mass, skin changes, nipple discharge, eccentric location)
- Need to differentiate true gynecomastia from pseudogynecomastia to guide management
The 2018 ACR guidelines emphasize that most men with breast symptoms can be diagnosed based on clinical findings alone without imaging 1.